Development and dosimetric characterization of an in vitro benchtop Am-241 alpha irradiator platform
Listen to this summary
The authors aimed to develop and characterize a benchtop in vitro alpha irradiation platform using an Americium-241 source to facilitate preclinical studies on the radiobiology of alpha particles in cancer therapy. They successfully constructed a system that ensures dose homogeneity and stability, demonstrating feasibility for controlled alpha particle irradiation with consistent dose rates. This platform is designed to support high-throughput research and long-term investigations into the effects of alpha radiation.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from International journal of radiation oncology, biology, physics
View all →Jun 11, 2026 · International journal of radiation oncology, biology, physics
PET-Guided Modeling of Mucosal Boron Heterogeneity Improves Dose-Toxicity Prediction in BNCT
Jun 11, 2026 · International journal of radiation oncology, biology, physics
Characteristics of Crowdfunding Campaigns for Proton Therapy
More in Radiology
View all →Jun 24, 2026 · Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
Point-of-Care Ultrasound M-Mode Analysis Using M.mode.ify: An External Validation Study for E-point Septal Separation Measurement
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
Jun 24, 2026 · Journal of the American College of Radiology : JACR
ACR Appropriateness Criteria® Chronic Knee Pain: Update 2026
Jun 24, 2026 · JAMA
Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain: A Randomized Clinical Trial
Jun 24, 2026 · Journal of the American College of Radiology : JACR
ACR Appropriateness Criteria® Myelopathy: 2026 Update
Jun 24, 2026 · The New England journal of medicine
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
